Finance

Beta
Lists
002332:SHE
Zhejiang Xianju Pharmaceutical Co Ltd
CN¥8.50
-0.70%
(-0.060) 1D
Jun 11, 3:04:42 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002332...
Open
CN¥8.54
High
CN¥8.62
Low
CN¥8.43
Mkt. cap
8.47B
Avg. vol.
7.81M
Volume
16.71M
Dividend
3.53%
Quarterly dividend
CN¥0.08
Ex-dividend date
May 28, 2026
P/E ratio
21.04
52-wk high
CN¥11.79
52-wk low
CN¥8.18
EPS
CN¥0.40
Shares outstanding
989.20M
No. of employees
3K
Open
CN¥8.54
High
CN¥8.62
Low
CN¥8.43
Mkt. cap
8.47B
Avg. vol.
7.81M
Volume
16.71M
Dividend
3.53%
Quarterly dividend
CN¥0.08
Ex-dividend date
May 28, 2026
P/E ratio
21.04
52-wk high
CN¥11.79
52-wk low
CN¥8.18
EPS
CN¥0.40
Shares outstanding
989.20M
No. of employees
3K
News stories
From sources across the web
About Zhejiang Xianju Pharmaceutical Co Ltd
CEO-
Employees3.21K
Founded1972
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
861.03M
956.35M
933.39M
918.35M
Cost of goods sold
262.82M
352.15M
431.84M
372.24M
Cost of revenue
262.82M
352.15M
431.84M
372.24M
Research and development expenses
55.16M
72.48M
105.33M
69.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
393.23M
383.78M
401.84M
358.84M
Operating expense
464.02M
451.01M
521.61M
433.08M
Total operating expenses
726.83M
803.16M
953.45M
805.32M
Operating income
134.20M
153.19M
-20.06M
113.03M
Other non operating income
323.20K
-10.52M
7.42M
-6.08M
EBT including unusual items
185.45M
114.02M
78.49M
108.30M
EBT excluding unusual items
136.67M
146.48M
-13.00M
108.54M
Income tax expense
27.52M
14.25M
21.76M
17.93M
Effective tax rate
14.84%
12.50%
27.72%
16.56%
Other operating expenses
14.01M
-5.42M
14.84M
3.17M
Net income
164.28M
98.42M
42.96M
93.89M
Net profit margin
19.08%
10.29%
4.60%
10.22%
Earnings per share
-
-
-
-
Interest and investment income
5.73M
3.31M
4.04M
2.32M
Interest expense
-1.49M
-1.59M
-1.42M
-725.41K
Net interest expenses
4.24M
1.73M
2.62M
1.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
190.76M
207.64M
33.50M
166.59M
Gain or loss from assets sale
-46.21M
46.21M
-46.30M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more